Hypoxia-mediated tumor progression, metastasis, and drug resistance are major clinical challenges in ovarian cancer. Exosomes released in the hypoxic tumor microenvironment may contribute to these challenges by transferring signaling proteins between cancer cells and normal cells. We observed that ovarian cancer cells exposed to hypoxia significantly increased their exosome release by upregulating Rab27a, downregulating Rab7, LAMP1/2, NEU-1, and also by promoting a more secretory lysosomal phenotype. STAT3 knockdown in ovarian cancer cells reduced exosome release by altering the Rab family proteins Rab7 and Rab27a under hypoxic conditions. We also found that exosomes from patient-derived ascites ovarian cancer cell lines cultured under hypoxic conditions carried more potent oncogenic proteins-STAT3 and FAS that are capable of significantly increasing cell migration/invasion and chemo-resistance in vitro and tumor progression/ metastasis in vivo. Hypoxic ovarian cancer cells derived exosomes (HEx) are proficient in re-programming the immortalized fallopian tube secretory epithelial cells (FT) to become pro-tumorigenic in mouse fallopian tubes. In addition, cisplatin efflux via exosomes was significantly increased in ovarian cancer cells under hypoxic conditions. Co-culture of HEx with tumor cells led to significantly decreased dsDNA damage and increased cell survival in response to cisplatin treatment. Blocking exosome release by known inhibitor Amiloride or STAT3 inhibitor and treating with cisplatin resulted in a significant increase in apoptosis, decreased colony formation, and proliferation. Our results demonstrate that HEx are more potent in augmenting metastasis/chemotherapy resistance in ovarian cancer and may serve as a novel mechanism for tumor metastasis, chemo-resistance, and a point of intervention for improving clinical outcomes.
Introduction
Hypoxia is considered a critical factor in promoting the spread of epithelial tumors [1] . Hypoxic ovarian cancer demonstrates an aggressive phenotype that includes increased drug resistance and an associated poor clinical outcome [2] [3] [4] [5] . The hypoxic tumor microenvironment favors the secretion of various chemokines that impact nearby tissues [6] . It is well known that all eukaryotic cells stay in contact with their local environment by transporting biological material across membranes via the secretion of small vesicles called "exosomes" that are endocytic in origin (40-100 nm in size) [7, 8] .
Research over the past few decades has revealed new facets of the role played by exosomes in the development and progression of many diseases, including cancer [9] . Aberrant activity of export machinery leads to expulsion of many proteins, RNAs [10] , and microRNAs (miRs) [11, 12] in pathological conditions, such as cancer. These cell contents, when transferred to recipient cells, can alter their biologic behavior, including intracellular signaling pathways [10] . Exosomal contents, therefore, have the ability to act as either tumor suppressors or promoters through their direct actions on a cell or by modifying the microenvironment [13] [14] [15] .
Rab proteins are a large family of small GTPases that play an important role in exosome secretion from cells. Previous work has shown that Rab27a and Rab27b act as 
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NEx HEx * ***key regulators of exosome secretion and are involved in cancer progression and tumor metastasis [16] . In addition, lysosomes serve as important organelles regulating the exosome secretion. Further, lysosomal changes in size, volume, and phenotype (Degradative/Secretory) in cancer cells can lead to drug resistance [17, 18] . As an example, changes in the lysosomal and exosomal pathways observed in cisplatin-resistant cells can increase the efflux of cisplatin, lowering the intracellular concentration of this drug [19] . We have shown previously that the oncogenic transcription factor, signal transducer and activator of transcription factor 3 (STAT3), is highly activated under hypoxia by hypoxia-inducible factor 1α (HIF-1α) in ovarian cancer [3, 20] . Therefore, we sought to investigate whether STAT3 is physically transported by exosomes and/or regulates the release of exosomes. We also examined whether the proteins released from cancer cells by exosomes are capable of affecting tumor progression, metastasis, and resistance in recipient cancer cells. In addition, we evaluated whether exosomes isolated from primary ovarian cancer cell (POCC) lines are capable of altering or reprogramming normal mouse fallopian tube secretory cells to pro-tumorigenic form.
Results
Isolation, characterization, and proteome profiling of normoxic ovarian cancer cell-derived exosomes (NEx) and hypoxic ovarian cancer cell-derived exosomes (HEx)
Exosomes isolated from immortalized ovarian surface epithelial cells (OSE385, 386), fallopian tube secretory cells , and ovarian cancer cell lines (OVCAR8, TR127, and TR182) were quantified for their concentration and size by nano particle tracking analysis (NTA) and normalized to the total cell count in each cell line used. The size of the isolated exosomes (30-120 nm) was within the expected range in all the cell lines. Exosome concentration was significantly higher in the cancer cell lines compared to immortalized ovarian surface epithelial cells (IOSE-385 and 386) and FT-33 (Fig. 1a, b) . Visual confirmation on the size and morphology was done using cryo-transmission electron microscopy (cryo-TEM; Fig. 1c , Sup. Figure 1A ) in different cell lines. In addition, the presence of exosome surface markers such as EpCAM, TSG101, and CD63 along with cis-Golgi protein GM-130, for vesicle purity, was confirmed in the exosome lysates isolated from different cell lines (OVCAR8 and TR127) in normoxia by western blots (Fig. 1d) . Since ovarian cancer is hypoxic in nature, the effects of oxygen tension on the release of exosomes from ovarian cancer cells were assessed by incubating cells for 48 h (in exosome-free culture medium) in normoxia (20% O 2 ) and under an atmosphere of 5% CO 2 -balanced N 2 to obtain 1% O 2 in an automated hypoxia chamber (BioSpherics™, Lacona, NY, USA). Cell number and viability was determined after each experimental treatment by Trypan Blue exclusion (data not shown). The fold change in the exosome release from different cell lines ranged from twoto-six-fold increase in hypoxia compared to normoxia across different cell lines with the maximal fold change observed in the POCCs derived from patient ascites (Fig.  1e) . As exosomes are known to carry biological information from host cells and also play an important role in intercellular communication in the tumor microenvironment, we analyzed the proteomic profile of the exosomes isolated from cancer cells and immortalized ovarian epithelial cells using one dimensional-liquid chromatography-tandem mass spectrometry (1D-LC-MS/MS). The data is represented as base peaks with significant overlaps showing differential protein expression between normoxic and hypoxic exosomes (Sup. Figure 1B , Sup. Table 1 ). Further, Gene Ontology (GO) Term analysis revealed that 90% of the total exosome proteins from both NEx and HEx were related to cellular processes, 70% to metabolic functions, and 60% biological regulations in HEx (Fig. 1f , Sup. Fig.2  A) . Gene symbols for our exosome protein data set were identified and subjected to Ingenuity Pathway Analysis (IPA). This analysis identified STAT3 as the top regulator effector network (Sup. Table 2 ) that was predicted to be activated downstream of the transforming growth factor β signaling pathway (Sup. Fig. 2B ). IPA also showed the top diseases and biological functions associated with our exosome protein data set involve cellular movement, growth, signaling, inflammation and cancer (Fig. 1g) . Overall, these results suggest that HEx carry diverse protein cargo that Fig. 1 Isolation and characterization of exosomes. a, b The concentration of exosomes released is higher in immortalized and primary ovarian cancer cells (POCCs) than in normal epithelial and FT cells normalized to the respective cell counts (n = 3 ± SD) as measured by NanoSight analysis. The size mode: 105 nm averaged from three technical replicates for each sample (n = 3 ± SD). c Cryo-TEM images of the exosomes isolated from OVCAR8 and TR127 cells (arrows indicate exosomes) (Scale bar = 100 nm) d Confirmation of exosomespecific markers such as EPCAM, CD-63, TSG-101, and GM130, a cis-Golgi apparatus protein for validation of vesicle purity, in the exosome preparation, confirmed by western blot. e Fold change in the exosome concentration isolated from different ovarian cancer cell lines and POCCs cultured in normoxia (20% O 2 ) and hypoxia (1% O 2 ) (n = 3 ± SD; p-value, *p < 0.05, **p < 0.005, ***p < 0.0001). f Gene Ontology (GO) Term analysis of the exosome protein data set shows that most of the exosomal proteins are related to cellular processes, metabolic processes, and biological regulation in the hypoxia exosomes when compared with the normoxia exosomes from OVCAR8 cells (p < 0.05). g Ingenuity Pathway Analysis of the exosome proteome data set shows the list of biomolecules identified in the data set to be associated with top six different diseases and functions. Fisher's exact test was applied to calculate significance (p < 0.05) could be associated with tumor progression, metastasis, and resistance.
Secretory lysosomal phenotype favors exosome release in hypoxia
Having confirmed that hypoxia induces (a) increased exosome release from ovarian cancer cells and (b) increased/ altered protein content in those exosomes, we next focused on investigating the changes in the lysosomes as they are important organelles involved in the exosome trafficking pathway. More peripheral lysosomal localization and docking toward the plasma membrane was observed using the lyso-tracker Red in hypoxic A2780 and OVCAR8 cells and their increased fluorescence intensity quantified by ImageJ (Fig. 2a, b) . Further, the lysosomal docking that might lead to its exocytosis was confirmed by the increase in the concentration of lysosomal hydrolase-BHexosaminidase-A in cell culture media in hypoxia when compared to that in normoxia (Fig. 2c) . On the contrary, the IOSE cells showed only a perinuclear distribution of the lysosomes (Fig. 2d ). In addition, the real-time gene expression of transcription factor EB (TFEB) that enhances lysosomal exocytosis (Supp. Figure 3A & B) was also increased under hypoxia along with the increase in lysosome-associated calcium channel mucolipin-1 (MCOLN-1) expression that also augments exosome release through the lysosomal exocytosis promoting cellular clearance under hypoxia.
Additionally, the co-localization of lysosome-associated membrane protein-1 (LAMP1), with lyso-tracker Red labeled lysosomes, visualized by fluorescence microscopy, confirmed the peripheral distribution of the lysosomes in the cells isolated from patient ascites (hypoxic environment) with ovarian cancer (Fig. 2e) . This demonstrates the clinical correlation of the secretory phenotype of the lysosomes that was observed under hypoxia in in vitro. Further, the protein expression levels of LAMP1/2 (Supp. Figure 3C ) were then analyzed in plasma membrane and cytosolic fractions of OVCAR8 cells cultured under normoxic and hypoxic conditions. LAMP1/2 protein levels were decreased, whereas mRNA expression levels were increased in hypoxic conditions compared to normoxia (Fig. 2f) . This implies a possible posttranslational modification may lead to decreased LAMP1/2 protein expression inside the cells, which then leads to increased exosomal release under hypoxic conditions. Since sialylated LAMP1 promotes lysosomal fusion to the cellular membrane leading to lysosomal exocytosis, we measured real-time expression of Neuraminidase-1 (NEU-1), which negatively regulates the sialylation of the LAMP1 and observed its downregulation in hypoxia, signifying (Fig. 2f) its role in lysosomal exocytosis. Additionally, in cancer cells under hypoxia we observed high mRNA expression of serpin-spi2A (Sup. Figure 4A ), a lysosomal protease inhibitor that is known to prevent the formation of leaky lysosomes. This observation clinically correlated well with high protein expression levels of spi2A in human ovarian cancer tissues when compared to benign and normal ovarian tissues (Sup. Figure 4B ).The higher expression of spi2A may favor the secretory role of lysosomes in ovarian tumor tissue. Our results suggest that downregulated NEU-1 mRNA levels in hypoxia could increase the accumulation of sialylated LAMP1, favoring lysosomal docking to the plasma membrane.
Evaluating the role of Rabs and STAT3 in exosome release
Given the central role of Rab GTPases in regulating multiple steps of vesicle trafficking, we analyzed Rab GTPases such as Rab5a, c and Rab15. These Rab GTPases are involved in early endosome formation and recycling. We also examined Rab7, a pivotal protein in endolysosomal fusion, and Rab27, a regulator of late endosome docking with the plasma membrane. Quantitative PCR analyses revealed increased Rab5a, c that are specific for endosome formation and an opposing effect of Rab15 indicative of reduced recycling (Sup. Figure 5A ). Further, in hypoxia, Rab7 and Rab27 protein and mRNA expression was inversely correlated (Fig. 3a, b) to favor the docking of multivesicular bodies (MVBs) at the plasma membrane by reducing the endolysosomal fusion. This was confirmed by the increase in B-Hexosaminidase concentration on treatment of OVCAR8 with Bafilomycin-A1, a known autophagy inhibitor that inhibits the fusion of late endosomes with lysosomes as previously shown in Fig. 2c . We observed similar results in ovarian cancer patient tissue samples, showing consistent expression of Rab27a and low or no expression of Rab7 (Supp. Figure 5C ). In relevance to the top regulatory network identified in our data set by IPA that shows the predicted activation of STAT3 in HEx, we have also observed constitutive expression of pSTAT3 in ovarian cancer patient tissues samples and hypoxic ovarian cancer cell lines [20, 21] (Supp. Figure 5C ), indicating that STAT3 activation might have a role in the exosome secretion pathway. Our results confirm a significant decrease in the exosome concentration in STAT3 knockdown (KD; Fig. 3c and Sup. Fig. 5B ) in OVCAR8 cells under hypoxia. Added to the previous results, the KD of STAT3 altered the Rab family proteins (Rab7 and 27a) (Fig.  3d) , suggesting a role for STAT3 in vesicular trafficking in ovarian cancer cells. The exosome concentration in OVCAR8 cells was measured using both positive and negative controls for STAT3 overexpression (OE) and KD indicated a plausible role for STAT3 in the exosome pathway (Fig. 3e) . Also a significant decrease in lysosome numbers in STAT3 KD cells was observed (Fig. 3f) , suggesting a role for STAT3 in lysosome biogenesis and vesicular trafficking in ovarian cancer cells. Further, we measured the exosome concentration in HIF-1α KD cells and confirmed that the exosome release was significantly influenced by STAT3 KD rather than hypoxia itself ( 
Evaluating the effect of HEx in migration/invasion in vitro
We next investigated whether HEx mediate the transfer of biological information to their recipient cells. To address this question, we (i) isolated exosomes from patient-derived POCCs, (ii) labeled the exosomes with exo-glow green, (iii) used confocal microscopy to view internalization of the labeled POCC exosomes by co-culturing them with OVCAR8 cells (Fig. 4a) , and (iv) we found that NEx or HEx (20 µg protein on alternate days), when co-cultured with other ovarian cancer cells, ovarian surface epithelial cells, or fallopian tube secretory cells (OVCAR8, IOSE, and FT, respectively) for a week, had a significant impact on cellular migration as shown by wound-healing assay ( Figure 6D ). A2780 and OVCAR8 cells co-cultured with NEx and HEx were also associated with increased levels of oncogenic proteins (such as pSTAT3-Y705) and proteins involved in migration/invasion (e.g., matrix metalloproteinase 2 (MMP2)) in the recipient cancer cells (Fig. 4e) . We further confirmed the expression of STAT3 within the exosomes of IOSE and OVCAR8 cell lines; interestingly, its activated form was observed only within the exosomes isolated from OVCAR8 in hypoxia (Fig. 4f) . Cultured patient ascites cells released high levels of exosomes when compared to those quantified from the immortalized cancer cells normalized to their cell counts (Fig. 4g , Sup. Fig.7 ). In relevance to the observation of pSTAT3 expression in cancer cells under hypoxia, a significant elevation of pSTAT3 Tyr705 in ascites and metastasis than in the primary tissue of ovarian cancer obtained from the same patient (Fig. 4h) indicates its importance in the spread of the disease. Moreover, exosomes isolated from patient ascites showed increased expression of pSTAT3 and FAS (Fig. 4i) which also adds to its influence on the cell migration/invasion in the recipient cells. This was further confirmed by the decrease in the migratory potential of the exosomes isolated from STAT3 KD cells when compared to exosomes from the STAT3 wild-type cells when co-cultured with the recipient cells (Fig. 4j) . These results suggest that HEx are in part responsible for the increased migratory and invasive potential of recipient cancer cells by the transfer of oncogenic protein STAT3 to the recipient cells.
Evaluating the tumor progression and metastatic potential of HEx in vivo using an orthotopic ovarian tumor model
To evaluate the aforementioned results in vivo, we used an orthotopic ovarian tumor model. This model consisted of OVCAR8 ovarian cancer cells co-cultured with NEx or HEx isolated from POCCs (20 µg) on alternate days for 3 weeks and then the exosome-treated OVCAR8 cells were injected into the ovarian bursa and observed for the tumors in vivo for 4 weeks. The mice injected with OVCAR8 cells co-cultured with HEx had significantly increased tumor growth and numerous metastatic nodules in the mesentery when compared to the mice injected with the same cells cultured with NEx ( Fig. 5a-d) . No significant changes were observed in the body weight of these mice (Sup. Fig.8A&B ). We observed a significant increase in the serum exosome concentration, along with the protein expression of pSTAT3 and MMP2/9 in the ovarian tissue of HEx-treated mice group (Sup. Fig. 8C, D&E) . Similarly, when FT cells were treated the same way as mentioned above by POCC exosomes and injected into the ovarian bursa, an increase in the size and weight of the fallopian tubes was seen (Fig. 5e , f). Hematoxylin-eosin staining of the fallopian tubes of HEx-treated mice showed hyperplasia ( Fig. 5g(i, ii) ) that was confirmed by increased cell proliferation marker-Ki67 ( Fig. 5g (iii, iv) & Sup. Fig: 10A&B ). In addition, immunofluorescent double-labeling performed in frozen tissue sections from control and HEx-treated fallopian tube showed increased Ki67 co-localization with the glandular epithelial cell-specific marker cytokeratin8 (CK8) showing epithelial specificity in the proliferating cells and increased Fig. 2 Hypoxia favors increased lysosomal docking to the plasma membrane. a, b The lysosomes labeled using the lyso-tracker Red dye were visualized by confocal microscopy in ovarian cancer cell lines (A2780 and OVCAR8) show a perinuclear localization in normoxia and a peripheral orientation favoring the docking to the plasma membrane in hypoxia, confirming a more secretory phenotype (60×) with higher fluorescence intensity in hypoxic cells than the normoxic cells as quantified by Image J (arrows indicate lysosomes) (n = 3 ± SD; *p < 0.01). c B-Hexosaminidase A concentration as a measure of lysosomal exocytosis by Competitve ELISA method shows increased concentration in Hypoxia and was further confirmed by the treatment of OVCAR8 with Bafilomycin-A1 (autophagy inhibitor) (1 µM for 24 h) vs normoxia (n = 3 ± SD; *p < 0.05 using Student's t-test). d The ovarian surface epithelial cells (OSE) show a perinuclear localization of the lysosomes in normoxia. e The peripheral lysosome colocalization (red) with LAMP1 (green) was further confirmed in cells isolated from patient ascites, which is a hypoxic environment. f The real-time gene expression levels of LAMP1 and 2 in 48 h period in hypoxia (HC-48) were increased when compared to normoxia (NC-48). Further, the downregulated mRNA expression of Neuraminidase 1 (a negative regulator of lysosomal exocytosis) as observed in hypoxia causes the accumulation of oversialylated LAMPs favoring the movement of lysosomes to the periphery of the cell (n = 3 ± SD; *p < 0.01, ***p < 0.001) using Student's t-test)
endothelial marker CD31 (Fig. 5h(i-iv) ) demonstrating the capability of HEx to increase the angiogenic potential in mice fallopian tube cells. Further, the expression of inflammatory cytokines such as interleukin-6 along with pSTAT3 was also increased in the fallopian tubes of HExtreated mice (Fig. 5i, Sup. Fig.11 ). Interestingly, we found that some of the genes involved in cell proliferation (STAT3, CycD1, CMyc, HGF) and tumor migration/ The protein and mRNA expression of Rab GTPases 7 and 27a were found to be inversely proportional in both Normoxia and hypoxia observed after 48 h. The reduced Rab7 might reduce the endo-lysosomal fusion augmenting the lysosomal exocytosis, which is further supported by increased Rab27a to release the exosomes in hypoxia (n = 3 ± SD; *p < 0.05, **p < 0.01 using Student's t-test). c The role of STAT3 in the exosome pathway was confirmed by measuring the exosome concentration isolated from STAT3 knockdown OVCAR8 cells cultured in hypoxia for 48 h and compared with the wild-type OVCAR8 in hypoxia (n = 3 ± SD; ***p < 0.005 using Student's t-test). d The knockdown of STAT3 significantly increased the expression of RAb7 and decreased Rab27a when compared to OVCAR8 WT (hypoxia) demonstrating its role regulating the Rab GTPases involved in vesicle trafficking. e Exosome concentration measured in STAT3 OE and KD OVCAR8 cells show the significant increase and decrease in the exosome concentration (n = 3 ± SD). f Also STAT3 knockdown cells showed a significant decrease of lysosomal numbers indicating its putative role in lysosome biogenesis under hypoxia. g Exosome concentrations were measured in HIF1α KD and STAT3 KD, and no significant changes were observed in HIF1 KD cells (n = 3 ± SD; NS-nonsignificant) invasion (MMP2) that reflected in their protein expression as well in the fallopian tube tissues and in the serum of the mice injected with FT cells treated with HEx (Sup. 
Effect of HEx on chemoresistance in ovarian cancer cells
A significant increase in serum exosome concentration, but not in the exosome size, after cisplatin treatment was observed in cisplatin-resistant ovarian cancer patients when compared with patients who were cisplatin sensitive and patients prior to treatment with cisplatin (Sup. Video 1-3, Fig. 6a , Sup. Fig. 12A&B ). The increase in exosome concentration in cisplatin-resistant patients might address a new area of exosomal involvement in drug resistance. We then investigated whether hypoxia impacts the exosomal efflux of cisplatin from ovarian cancer cells. A five-fold increase of cisplatin content in HEx vs NEx isolated per million cells in TR127, TR182, and A2780 cells was noted, as measured by inductively coupled plasma mass spectrometry (ICP-MS; Fig. 6b ). We then analyzed whether HEx cocultured with ovarian cancer cells could induce resistance to cisplatin treatment. Sulforhodamine B (SRB) assay indicated that pretreatment of the ovarian cancer cells with HEx increased the resistance to cisplatin treatment with increased cell survival rate when compared to the control OVCAR-8 cells without the HEx treatment group (Fig. 6c, Sup.  Fig.12C ). This effect of HEx on cisplatin treatment in OVCAR8 cells was further confirmed by the significant reduction in the ɣH2Ax-positive cells and the apoptotic protein expression levels by western blot analysis (Fig.  6d-f) . When OVCAR8 cells were treated with amiloride, a known exosomal inhibitor, decreased exosomal release was measured by NTA (Fig. 6g) . Confocal microscopy further confirmed a finding indicative of the absence of secretory lysosomal phenotype showing perinuclear localization (Fig.  6h ). In addition, we have confirmed the significant inhibition of cell growth and colony formation in amiloride pretreatment and co-treatment with cisplatin. (Fig. 6i , j, Sup. Fig. 13A&B ). This may prove effective in combating the chemoresistance mediated by exosomal efflux of cisplatin for which further studies are warranted both in vitro and in vivo. Overall, these results suggest that hypoxia-induced cancer exosomes contribute to chemoresistance by a drugefflux mechanism.
Discussion
In this study we examined the role of hypoxia, and the regulation of Rab proteins by STAT3, in the release of exosomes in ovarian cancer. We have shown that altered lysosomal phenotype in multiple ovarian cancer cell lines and patient-derived ascites under hypoxic conditions favors increased exosome release by reduced endolysosomal fusion that was confirmed by increased B-Hexosaminidase-A activity and increased real-time expression of TFEB that favors the lysosome docking under hypoxia in ovarian cancer cells. We have also demonstrated that STAT3, when induced under hypoxic conditions, regulates Rab7 and Rab27a proteins so as to promote exosome release in ovarian cancer cells, in conjunction with an altered lysosomal phenotype. Exosome-mediated transfer of oncogenic proteins was capable of promoting tumor progression and metastasis in an orthotopic mouse tumor model and was also capable of reprogramming the FT cells to increase the expression of proteins associated with inflammation, cell proliferation, and tumor progression in the mouse fallopian tube. Moreover, hypoxia-induced changes in exosome secretion may play a role in chemoresistance, as cisplatin Fig. 4 Exosome internalization and its influence on the tumor migration and metastasis in the recipient cells. a Exosomes isolated from hypoxic ovarian cancer cells were labeled with exo-glow-green (System Biosciences-SBI), and co-cultured with the OVCAR8 cells in conditioned medium. The exosome internalization after 24 h was confirmed by confocal microscopy. Differential contrast image (DIC) shows that exosomes are internalized. b The percentage of migration was quantified using the Image J software in normal (OSE and FT-33 cells) and ovarian cancer cell lines (OVCAR8) with and without HEx co-culture (n = 3 ± SD; **p < 0.05 using Student's t-test). c, d Invasive potential of the OVCAR8 cells was analyzed using the Cell Invasion Transwell Assay Kit. The number of cells invading the membrane was significantly increased after 48 and 72 h when co-cultured with HEx and quantified as a percentage of invasion as shown (n = 3 ± SD; **p < 0.005 using Student's t-test. e NEx and Hex (20 µg on alternate days) was co-cultured with A2780 and OVCAR8 cells in conditioned medium under normoxia for a week and observed an increase in the protein expression of activated STAT3 and proteins involved in tumor progression and metastasis-MMP2. f To investigate the transport of STAT3 via exosomes, the expression of STAT3 in the IOSE and cancer cell exosomes showed the presence of pSTAT3 in the exosomes derived from cancer cell line (OVCAR8) but absent in normal cell (IOSE) exosomes, though total STAT3 was seen in both normal and cancer cell exosomes. g Primary cells isolated from different patient ascites (n = 6 ± SD, Stage IV) were cultured in conditioned medium for 48 h and the exosome concentration measured by NTA showed higher magnitude ( 10 11 ) of exosome release when compared to the magnitude released from immortalize cancer cells (10 9 ) in normoxia, normalized to their respective cell counts (10 7 ). h pSTAT3 expression in primary ovarian tumor tissues, ascites, and metastatic tissues (n = 3 ± SD, *p < 0.05, **p < 0.005, ***p < 0.001) from the same patient show increased STAT3 activation in the ascites and metastatic sites than the primary tumor site implying the role of STAT3 in tumor progression and metastasis. i The expression of oncoproteins such as STAT3, pSTAT3, and FAS were confirmed in the exosomes isolated from patient ascites normalized to the EpCam expression. j Migration assay proved the role of exosomal STAT3 using exosomes isolated from both STAT3 WT and STAT3 knockdown (KD) cells. The OVCAR8 cells co-cultured with exosomes from STAT3 KD cells for 48 h significantly decreased the migration potential of OVCAR8 cells efflux via exosomes was increased in ovarian cancer cells co-cultured with hypoxic-derived exosomes (Fig. 7) .
The mechanisms of exosomal release by the tumor cells and its contribution to tumor metastasis and drug resistance likely play an important role in cancer biology [22] [23] [24] [25] [26] . 
C
Changes in the lysosomal phenotype observed in hypoxic conditions might be the reason for peripheral shift of secretory or exocytic lysosomes outward, to the plasma membrane [18, 19] . We also found that this might be due to downregulation of NEU-1 that led to the accumulation of over-sialylated LAMP1 which favors the movement of lysosomes toward the plasma membrane to release their contents, which confirms NEU-1 as a negative regulator of lysosomes exocytosis [27] . In addition, increased activity of secretory Rab proteins in the exocytic endosomal pathway favored the release of exosomes. Hypoxic ovarian cancer cells release more exosomes through enhancing the secretory pathway of the formed MVBs by Rab GTPases. Previous reports have shown that the expression of Rab family proteins determines the aggressiveness of ovarian and breast cancer and leads to resistance to platinum-based chemotherapy [22] . However, there is no clear evidence as to which Rab proteins are specifically involved in the vesicle trafficking in ovarian cancer. As observed in our study, Rab5 and Rab15 have opposing effects. This suggests that Rab5 favors the early stages in the formation of endosomes and reduced Rab15 indicates a decrease in recycling of endosomes. We confirmed that the real-time expression of Rab7, a mediator of lysosomal endocytic degradation, was downregulated and Rab27a, a regulator of vesicle exocytosis, was upregulated [16, 28] . We then investigated the role of STAT3 in this pathway given findings from a previous study which showed that OE of STAT3 increased lysosomal-mediated cell death during the physiological process of mammary gland involution [29] . However, we have previously shown that, in the pathologic condition of ovarian cancer, cell death is evaded by high expression of STAT3 under hypoxic conditions [3, 21] . Our current study suggests that high expression of STAT3 might have a different impact on the lysosomal phenotype, which is an important feature indicating the exosome release enhanced by alteration in the Rab GTPases in hypoxic ovarian tumor. Given the hypoxic microenvironment of ascites in ovarian cancer, exosomes released from tumor cells in ascites carry oncogenic proteins that can alter the signaling pathways in the surrounding recipient tumor cells or normal cells, favoring tumor progression and metastasis [24, [30] [31] [32] . We have shown that activated STAT3, FAS, and other oncogenic proteins were detected in HEx and patient-derived ascites. There is emerging evidence that cancer-derived exosomes may also contribute to the recruitment and reprogramming of the tumor microenvironment to form a pro-tumorigenic niche [33, 34] . Here we observed that HEx has a similar effect on immortalized FT in vivo. Recent studies have demonstrated that cancer exosomes are potential mediators of premetastatic niche formation, enhance VEGFR1 expression, and angiogenesis in human renal cell carcinoma stem cells [35, 36] . Others have also suggested that vesicles in ascites may serve as stores of active proteinases that may aid in the metastatic process [37, 38] . Our study involving co-culture of HEx supports the hypothesis that epithelial tumor spread is also facilitated by the action of secreted exosomes on the surrounding cells/tissues in the tumor microenvironment.
Further, HEx may play a significant role in resistance to anticancer therapy. Previous reports have shown that exosomes may be responsible for drug efflux and chemoresistance [13, 19, 39] ; the current study confirms this finding and suggests that it is enhanced in the setting of hypoxia, and as most of our results correlated with clinical samples, it is yet to be determined whether targeting these exosomalmediated pathways can overcome platinum resistance in ovarian cancer. However, directly targeting Rab proteins or Rab-regulating proteins such as STAT3 using novel smallmolecule inhibitors may increase treatment success in combination with platinum-based drugs in hypoxiamediated chemoresistant ovarian cancer. The ovarian bursa of mice were injected with POCC exosome-treated OVCAR8 cells after 3 weeks of co-culturing with NEx and HEx (20 µg on alternate days). The tumor weights were significantly increased after 4 weeks in OVCAR8 HEx-injected mice when compared to NEx or control OVCAR8-injected mice (n = 4 ± SD *p < 0.05). c, d The number of metastatic nodules was significantly higher in mice injected with OVCAR8 cells, which were co-cultured with HEx than those injected with OVCAR8 cells co-cultured with NEx and control (n = 3 ± SD, **p < 0.005). e A similar experiment was done in mice injected with fallopian tube secretory cells that were co-cultured with NEx and HEx (20 µg on alternate days) for 3 weeks to see the capability of the exosomes to reprogram FT cells. No tumors were observed after 4 weeks but a significant change in the morphology of the fallopian tube was observed in all the mice injected with FT cells previously co-cultured with HEx for 4 weeks. f The weight of the fallopian tube with the ovary was significantly higher in the HEx when compared to the NEx or control (n = 3 ± SD,**p < 0.005). 
Materials and methods
Cell lines used in the current study IOSE (385 and 386) and human FT (gifted by Dr. Ronny Drapkin, University of Pennsylvania, US), were used along with two immortalized high-grade serous ovarian cancer human cell lines: OVCAR8 and A2780. The TR127 and TR182 cell lines (gifted by Dr. G. Mor of Yale University), were derived from recurrent, chemotherapy-resistant ovarian cancer. In addition, ascite-derived POCCs isolated from different ovarian cancer patients were cultured as explained in the supplementary method section. The primary reason for using different cell lines was to prove that tumor progression and metastasis patterns vary widely in immortalized vs POCC lines isolated from patient ascite cell lines.
We confirmed all the cell lines for mycoplasma activity using the ATCC ® Universal Mycoplasma Detection Kit, every 2 months. Once the frozen cells were thawed, they were passaged for five times only, and discarded thereafter and a fresh vial was thawed.
Exosome isolation from culture medium, patient ascites, and serum
To isolate tumor exosomes from culture media, the immortalized ovarian cancer cells were cultured for 2 days (48 h) in medium with exosome-depleted fetal bovine serum (purchased from System Bioscience, CA, USA). The conditioned medium was centrifuged at 400 × g for 10 min to remove whole cells and this supernatant was then centrifuged at 10,000 × g for 30 min to remove large microvesicles and apoptotic vesicles and then the supernatants were filtered through 0.22 μm porous membranes followed by a spin at 100,000 × g for 1 h at 4°C to isolate the exosomes. Next, the exosomes pellet was washed in 10 ml 1× phosphate-buffered saline (PBS) followed by a second step of ultracentrifugation at 100,000 × g at 4°C for 1 h. The final pellet was re-suspended in PBS and the vesicular protein concentration was determined using the BCA protein assay from ThermoFisher Scientific (Waltham, MA) according to the manufacturer's instructions. The patients' serum used in the current study were frozen samples and the ascites were obtained fresh from different patients undergoing surgery and were approved based on the Ohio State Fig. 6 HEx is involved in chemoresistance. a Quantification of serum exosome concentration in ovarian cancer control (before cisplatin treatment), cisplatin-sensitive (no disease recurrance >6 months after treatment) and cisplatin-resistant (disease recurrance <6 months after treatment) patient samples (n = 5 ± SD, ***p < 0.005) show increased exosomal concentration/ml of serum. b The measurement of cisplatin concentration in exosomes after treatment with cisplatin for 24 h using ICP-MS in different ovarian cancer cell lines cultured in normoxia and hypoxia shows a significant efflux of the platinum via exosomes in hypoxia than in normoxia (n = 8 ± SD) (**p < 0.005, ***p < 0.0001using Student's t-test). c The percentage of cell proliferation determined by sulforhodamine assay was found to be significantly increased by co-culturing the OVCAR-8 cells with Hex (20 µg) when compared to the control group (n = 8 ± SD, ** p < 0.005, ***p < 0.0001 using Student's t-test). d, e The OVCAR8 cells without any exosome treatment show an increase in ɣH2Ax-positive cells on treatment with cisplatin at 10 µM for 24 h when compared to the HEx pretreated OVCAR8 cells and was quantified based on the number of ɣH2ax-positive cells (n = 3 ± SD; **p < 0.005, ***p < 0.0001). f A reduction in cisplatin sensitivity, despite STAT3 inhibition by HO-3867 treatment for 3 h prior to cisplatin treatment, was observed via reduced apoptotic protein expression of cleaved PARP and caspases 3 and 7 in HEx-treated OVCAR8 cells, when compared the OVCAR8 cells without any prior exosome treatment, Lane: 1 (Control), Lane: 2 (DMSO), Lane: 3 (HO3867-10 µM, STAT3 inhibitor), Lane: 4 (Cisplatin-10 µM), Lane: 5 (HO3867+CP). g The exosome concentration under hypoxia in OVCAR8 cells quantified by NTA showed a significant decrease upon treatment with 100 µM amiloride (n = 3 ± SD; **p < 0.005). h The treatment of OVCAR8 cells in hypoxia with a known exosome inhibitor, amiloride, reduced the peripheral localization of the lysosomes labeled with lyso-tracker Red dye when compared to cisplatin treatment where more peripherally oriented lyosomes were observed as captured by confocal microscopy. i, j The cell survival and colony-formation assay using OVCAR8 cells shows that amiloride (100 µM), when treated alone, is not cytotoxic when compared to control, but when co-treated with cisplatin (10 µM) did increase in the cytotoxic effects in 24 h as compared with cisplatin treatment alone (n = 3 ± SD; **p < 0. University IRB (Study number 2004C0124). Isolation and characterization of patient ascite cells are as described previously [40] . For isolation of exosomes from 250 μl of cell-free serum and ascites, samples were thawed on ice. Samples were diluted in 11 ml 1× PBS and filtered through a 0.2 μm pore filter and then followed the same protocol as described above for the cell culture medium. The resulting exosome pellet was re-suspended in 100 µl of cold PBS or lysis buffer according to the downstream applications such as NTA, TEM, and western blotting as we previously described [41, 42] .
Nano particle tracking analysis
This technique is particularly powerful and sensitive for analyzing particles with a mean diameter of <100 nm exosomes. For reliable NTA measurement, we used an appropriate exosome sample dilution that provides approximately 20-100 particles in the field of view. NTA post-acquisition settings were optimized and kept constant between samples, and each video was then analyzed to give the mean, mode, and median particle size together with an estimated number of particles per mL serum or per 10 7 cells. We recorded three 10 s videos on the NanoSight LM10, which were analyzed using the tracking software. The NTA software plots particle size range vs particle number in the sample [43] . A total of 100 nm polystyrene latex microspheres were routinely analyzed to confirm instrument performance.
EXOCET assay
This assay directly measures acetyl-coa acetylcholinesterase activity, known to be enriched within exosomes [44, 45] . The EXOCET exosome quantitation system is an enzymatic, colorimetric assay read at OD 405 . A standard curve that has been calibrated to isolated exosomes by NanoSight analysis is included in the kit, which enables the number of exosomes to be measured in our samples.
Cryo-TEM
Cryo-TEM specimens of the exosome solutions were prepared using thin-film plunge freezing in a FEI Vitrobot (Mark IV). The vitrified specimens were mounted onto a Gatan 626.DH cryo-holder. Cryo-TEM observation was performed using low-dose mode on a FEI Tecnai F20 TEM according to a previously published protocol by Gao et.al. (2014) [46] .
Confocal microscopy
Confocal microscopy images were collected with a FluoView 1000 laser scanning confocal microscope (Olympus, Center Valley, PA) using a 1.42 N.A., 60X, oil immersion objective.
Determination of cisplatin accumulation in cells and exosomes by ICP-MS
Cisplatin accumulation/efflux by cells via exosomes was measured in different cell lines using OVCAR8, TR127, and A2780 cells by ICP-MS analysis. Samples were analyzed on a Perkin Elmer Elan 6000 ICP-MS set-up for a sample uptake of 0.1 mL/min 194 Pt, 195 Pt, and 196 Pt using 115 In as an internal standard (standardized at Trace Elements Lab., OSU). The samples were measured with eight replicates averaged and then the average concentration of the isotopes was used as the final concentration for a single result per sample. Blanks were processed simultaneously with the samples to nullify the Pt contamination throughout the process.
STAT3 OE and KD experiments
For upregulation and downregulation of STAT3 in OVCAR8 cells, a lentiviral system (pGIPZ) from Santacruz Biotechnology with a set of different short hairpin RNAs (shRNAs) was used. The resultant STAT3 KD cells were called as OVCAR8 KD cells. A negative scrambled shRNA was used as a control [41] .
SRB assay
Cell proliferation rate in ovarian cancer cells treated with Hex and cisplatin was determined by a colorimetric assay using SRB, as described previously [40, 47] .
Protein extraction and digestion for LC-MS/MS
Exosome pellets were re-suspended in 100 µL (50 µL for normal cell controls) of 50 mM ABC containing 0.5% Rapigest (Waters Corp.), sonicated 2× for 10 s, and incubated with shaking for 1 h at room temperature, and protein concentration was determined by the Bradford assay. Further, the samples were digested with trypsin and the peptide concentration was determined by nanodrop (A280 nm).
Development of orthotopic tumor model
STAT3 OE OCC cells (3 × 10 6 cells in 100 μL of PBS) were injected into the ovarian bursa of 6-week-old BALB/c nude mice from the OSU Transgenic mice core laboratory. In vivo magnetic resonance imaging was done periodically to check on the tumor growth. After sacrifice, the tumor weight and volume were measured. The animal protocol has been approved by OSU IACUC (Protocol number 2012A00000008-R1), and we have followed vertebrate ethical regulations in this study.
Statistical analysis
Data are presented as mean ± 1 standard deviation. To determine statistical significance among groups, analysis of variance (ANOVA) was first performed. If ANOVA was statistically significant, Student's t-test was then performed to compare subgroups; p-value < 0.05 was considered as statistically significant (detailed methods are in Supplementary file).
